CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy.

Al Barashdi, Maryam Ahmed S; Ali, Ahlam; McMullin, Mary Frances; Mills, Ken

Al Barashdi, Maryam Ahmed S; Ali, Ahlam; McMullin, Mary Frances; Mills, Ken.

Afiliação

Al Barashdi MAS; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, UK.
Ali A; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, UK.
McMullin MF; Haematology Department, C-Floor Tower Block, Belfast City Hospital, Belfast, Northern Ireland, UK.
Mills K; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, UK. k.mills@qub.ac.uk.

Ann Hematol ; 103(1): 73-88, 2024 Jan.

Article em En | MEDLINE | ID: mdl-37917373

Assuntos

Leucemia Mieloide Aguda; Leucemia Mieloide; Transtornos Mieloproliferativos; Humanos; Idoso; Leucemia Mieloide/tratamento farmacológico; Pirazóis/uso terapêutico; Nitrilas/uso terapêutico; Citarabina; Transtornos Mieloproliferativos/tratamento farmacológico; Leucemia Mieloide Aguda/tratamento farmacológico; Leucemia Mieloide Aguda/genética; Leucemia Mieloide Aguda/metabolismo

Palavras-chave

AML; CD45; Common leukocyte antigen (CLA); Myeloid leukaemia; PTPRC

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Leucemia Mieloide / Transtornos Mieloproliferativos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google